Clinical Trial Patient Recruitment Landing Pages: What Actually Converts Under IRB

In summary

• A dedicated recruitment page outperforms the institutional study listing because it answers one question — “am I eligible and what happens next” — instead of describing the protocol.
• Everything on the page is recruitment material in the IRB’s eyes: headline, ad copy, eligibility bullets and pre-screener wording are approved as a package, not as a live-editable webpage.
• Build for one approved version with two or three variants pre-approved in the same submission, because an amendment cycle can outlast the test you wanted to run.
• A pre-screener should filter, not diagnose. Collect the minimum needed to route someone to a coordinator, and keep identified health answers out of any tool without a BAA.
• Unbounce: Starter $29/mo ($22 annual); Build $99/mo ($74); Experiment $149/mo ($112, unlimited A/B); Optimize $249/mo ($187, Smart Traffic). 25% off annual. Verified 18 August 2026.
• Measure enrolled participants, not clicks — a page with a 40% form rate and a 2% consent rate is worse than one with 12% and 30%.

Institutional study page vs dedicated recruitment page

Unbounce pricing verified from the vendor pricing page, 18 August 2026

Dimension	Study page on the .edu / .nhs.uk site	Dedicated recruitment page
Who it is written for	Reviewers, referring clinicians, registry crawlers	A person wondering whether this applies to them
Time to publish a wording change	Web-team ticket, often weeks, on top of IRB approval	Minutes once the wording is approved
Paid traffic	Usually blocked — comms teams will not run ads to a subpage	Built for it; one page, one campaign, one budget
Pre-screener	Generic contact form or a phone number	Short eligibility filter routing to a coordinator
Variant testing	Not possible without CMS work	Unlimited A/B from Experiment ($149/mo, $112 annual)
Attribution to enrolment	Site-wide analytics; study traffic is indistinguishable	Per-campaign, traceable through to consented participants
Handles identified health answers	Depends entirely on your institution’s stack	No — needs a BAA-covered form or an embedded REDCap/EDC handoff

Neither column is “the right answer” on its own. Most compliant setups run both: the institutional page as the canonical, registry-linked record, and the recruitment page as the front door for paid and social traffic.

Why the study page on your institution’s site does not recruit

The page you already have was written to satisfy a different audience. It leads with the protocol title, the sponsor, the registry identifier and a paragraph of inclusion criteria copied out of the protocol document. That is exactly correct as a public record of the study. It is close to useless as the destination for someone who saw a post, wondered whether they qualified, and clicked.

Three structural problems repeat across almost every institutional site we look at. The first is navigation depth: the study sits under a research directory, under a department, under a faculty, and nothing links to it from anywhere a patient would begin. The second is that the page is not editable by the study team — a wording change goes through a web ticket, so the page ossifies at whatever the first draft said. The third is that comms and marketing teams will generally not point paid traffic at an arbitrary institutional subpage, because the page has no campaign tracking, no consistent call to action, and no owner who can be held to a conversion target.

The result is a page that ranks for the study title and nothing else, receives traffic only from people who already knew the trial existed, and offers them a departmental phone number. Meanwhile the recruitment shortfall gets addressed with more flyers, more clinic referrals and more of the coordinator’s time — all of which cost more per enrolled participant than a page that answers the eligibility question in ten seconds.

The reader looking for research participant recruitment in a non-clinical setting — a behavioural study, a cohort survey, a device usability panel — has the identical problem with softer regulatory edges. Everything below applies; you simply have fewer constraints on the wording and a lower bar on what counts as sensitive.

What a recruitment page has to do that the study listing does not

A recruitment landing page has one job: move a self-identified maybe into a qualified conversation with a coordinator. Everything on it should serve that. In practice that means a specific structure, and the order matters more than the design.

• Lead with the condition and the location, not the protocol title. People search for their diagnosis and their city. “A study for adults with treatment-resistant hypertension in Greater Manchester” outperforms any acronym.
• Answer eligibility in bullets a person can self-assess. Age range, diagnosis, the two or three exclusions that disqualify most people. Not the full criteria list — the filter, so people who obviously do not qualify leave without occupying coordinator time.
• Say what participation actually involves. Number of visits, how long each takes, what procedures, whether travel or time is reimbursed, and over what period. This is the single most-requested piece of information and it is almost always missing.
• Be explicit that this is research. Not treatment, not a guarantee of benefit, and that participation is voluntary and withdrawable. This is both a regulatory expectation and, in our experience, a trust signal that improves rather than harms conversion.
• One call to action, repeated. A short pre-screener or a request-a-call form. Not a phone number, an email address, a PDF and a form all competing.
• Name the site and the investigator. Anonymous recruitment pages read as scams, and a plausible number of your visitors have been warned to be suspicious of exactly this kind of advert.

Notice how little of this is design work. The constraint is not that you cannot build a good page — it is that the good page says things the current page does not, and every one of those things needs approval before it goes live.

IRB approval turns your page into a regulated document

This is what makes clinical trial recruitment different from ordinary marketing, and it is the part most agencies get wrong. Your IRB or research ethics committee reviews recruitment materials, and a landing page plus the adverts that drive traffic to it are recruitment materials. The approval is of a specific wording package — headline, body text, eligibility summary, imagery, the ad copy, and the pre-screener questions. Change any of it materially and you are running unapproved material.

Three categories of language reliably cause problems. Implied benefit: anything suggesting the investigational treatment works, is better than standard care, or that participants will improve. “New treatment” and “breakthrough” fall into this. Undue inducement: leading with the payment figure, or framing reimbursement as earnings, rather than presenting compensation as a factual detail further down. Language that functions as consent: a page cannot enrol anyone, and wording that implies signing up on the page commits someone to the study — or that the pre-screener determines eligibility — blurs a line the consent process exists to keep sharp. The page qualifies interest; a human confirms eligibility and consent happens separately.

The practical consequence for tooling: you cannot iterate on live copy. The instinct from ordinary conversion work — ship a change, watch the numbers, ship another — is not available to you. Which is why the tool choice is not really about editor quality. It is about whether the tool lets you hold multiple approved wordings and switch between them without touching text that is under review.

Pre-screener design: filter without collecting data you have no basis to hold

The temptation is to put the full screening questionnaire on the page so coordinators only speak to qualified people. Resist it. The moment your form collects identified health answers — a diagnosis, a medication, a symptom score attached to a name, email or phone number — you are processing protected health information, and the tool holding that submission needs to be covered by a business associate agreement (or, under UK GDPR, an appropriate processor agreement with special-category data properly grounded). Most default page builders, including Unbounce, are not that tool. Nor are most default form and email services.

There are three workable patterns:

1. Interest-only capture. The page collects name and contact preference and nothing clinical. Eligibility bullets do the filtering visually; a coordinator screens by phone. Simplest, most defensible, and works with any builder. The cost is coordinator time on unqualified calls.
2. Unidentified pre-screen, then handoff. Two or three yes/no eligibility questions answered before any contact details are requested, with the answers used only to branch the page. If someone does not qualify, they see a thank-you and no submission is stored. If they do, contact details are captured for a callback. Keep the clinical answers out of the stored record.
3. Embedded covered form. The marketing page hosts the approved copy and the traffic; the actual screening form is an embed or a link out to REDCap, your EDC, or another BAA-covered system that your institution already runs. This is the pattern most academic medical centres end up on, and it is the one we would default to when real screening data must be captured.

Whichever you choose, the page needs a plain-language privacy statement saying who receives the information, that it is used to contact them about this study, and that submitting it does not enrol them. Sending the resulting details around by email is its own problem — if your workflow involves faxing screening forms between sites, only a HIPAA-covered service with a signed BAA is acceptable, and for Fax.Plus that is the Enterprise tier at $79.99/mo for 4000 pages, the only tier that includes HIPAA and a BAA. Verified 18 August 2026. Consent and re-consent documents have the same requirement; see our notes on electronic signature software and HIPAA-compliant fax for the tiers that actually carry a BAA.

The two trade-offs nobody mentions before you buy

An amendment cycle can outlast the test you wanted to run. Conversion optimisation assumes a fast loop. Yours is measured in the time it takes to get a modification reviewed, which at many institutions means weeks and at some means a full board meeting. If your study recruits for six months, you may realistically get two or three wording changes approved in that window. So do not build a testing programme; build one approved version, and submit two or three variants in the same initial package so they arrive pre-approved. Vary one meaningful thing per variant — the headline framing, the position of the time commitment, whether the pre-screener comes before or after the eligibility list. Then the tool’s job is only to split traffic between things you are already allowed to say.

This is precisely where Unbounce’s Experiment tier earns the difference over the cheaper plans: unlimited A/B at $149/mo ($112 annual) means the number of pre-approved variants you can run is not a billing decision. Optimize at $249/mo ($187 annual) adds Smart Traffic, which allocates visitors to variants automatically — useful when you have three approved wordings and not enough volume to reach significance on any of them before recruitment closes. Verified 18 August 2026.

Any form capturing screening answers needs a BAA-covered tool, which rules out most page builders. This is not a knock on Unbounce specifically — it is true of essentially every mainstream landing page product, and vendors that market a HIPAA posture usually gate it behind an enterprise contract with a very different price. Assume the split: marketing page in the page builder, screening data in a covered system. Anyone selling you a single tool that does both, at self-serve pricing, is either quoting an enterprise agreement or has not thought about it.

Do not buy a landing page builder if any of the following is true. Your enrolment shortfall is a referral problem rather than an awareness problem — if the eligible population only exists inside two clinics, a page and an ad budget will not find them, and coordinator time on site is better spent. Your study is already at or near target and the shortfall is in one stratum, where targeted outreach beats broad traffic. Your institution flatly forbids study material on non-institutional domains, which some do — check before you buy, because a subdomain arrangement can take longer to negotiate than the recruitment window. Or your budget cannot cover ad spend on top of the tool: the page is the conversion half, the traffic is the other half, and at a $35.14 average cost-per-click in this category a page with no media budget behind it is an expensive way to publish a document.

Report enrolled participants, not clicks

The default analytics for a landing page tell you about clicks, form submissions and cost per lead. None of those is the number your sponsor, your PI or your funder cares about. The chain that matters is: impression → click → pre-screen completed → screening call held → screened eligible → consented → enrolled. A page optimised for the third step will happily wreck the seventh, because the easiest way to raise form submissions is to make eligibility vaguer, and vaguer eligibility produces unqualified calls that consume the coordinator time you were trying to save.

Set it up so that each campaign and each approved variant carries a tracking parameter that persists into whatever the coordinator records against the participant, even if that is a spreadsheet column labelled “source”. Then your monthly recruitment report can say which variant produced enrolments rather than which produced leads. When the two disagree — and they usually do — trust the enrolment figure and change the page in the direction of more specificity, not less.

Two practical notes. Be careful with third-party tracking pixels on a page reached by people with a specific diagnosis; the fact that someone visited a page about a named condition is itself sensitive, and a number of health systems have had to unwind exactly this. Keep advertising pixels off the pre-screener and thank-you steps at minimum, and check your institution’s position before adding any. And keep a dated archive of every approved variant, its live dates and its results — you will need it for the recruitment section of your progress report, and reconstructing it afterwards from a page builder’s version history is miserable. For the general mechanics of measuring page performance, our notes on conversion rate optimisation tools cover the tooling; the discipline above is what makes it applicable to a trial.

A realistic recruitment stack for an academic site

For a single-site or small multi-site academic study, the setup that survives contact with both the IRB and the finance office looks like this. The page itself lives in Unbounce — Build at $99/mo ($74 annual) if you are running one approved version, Experiment at $149/mo ($112 annual) once you have pre-approved variants to split. Verified 18 August 2026. Traffic comes from paid search on the condition plus geography, and from targeted social; both ad creatives go through the same approval package as the page.

Screening data, if you capture any, goes to REDCap or your institution’s covered form system, embedded or linked. Consent documents go through a signature tool on a tier that carries a BAA — for Sign.Plus that is Enterprise at $49.99/mo, though audit trails and eIDAS are included on all tiers, which matters for European sites. Verified 18 August 2026. If your recruitment involves an ongoing participant community — a registry, a rare-disease cohort, a long-running panel you re-recruit from — a membership platform is a better home for that than a mailing list; see our comparison of community platforms. And if you are coordinating recruitment social posts across several sites with different comms teams needing to approve them, staged approvals in a scheduler are worth more than the scheduler itself; our scheduler comparison covers which tiers include multi-stage approval.

Total tooling cost for the page layer sits in the low hundreds per month. The honest framing for a budget conversation: that figure is small relative to the cost of a study running three months past its recruitment deadline, and small relative to the ad spend it is there to convert. It is not small relative to doing nothing, and if the page will not get paid traffic pointed at it, it is not worth buying.

Build the approved version once, then test within it

Unbounce lets a study team publish and switch pre-approved recruitment wordings without a web ticket, and hold pending variants in draft while the amendment clears. Starter $29/mo ($22 annual); Experiment $149/mo ($112 annual) for unlimited A/B. Verified 18 August 2026. Pair it with a BAA-covered system for anything clinical.

From $29/mo ($22 billed annually)

See Unbounce pricing Opens on the vendor’s site · CASRAI referral link

Frequently asked questions

Does a landing page for clinical trial patient recruitment need IRB approval?

Assume yes. Most IRBs and research ethics committees treat anything a prospective participant sees before consent as recruitment material, and that includes the landing page, the advert driving traffic to it, and the wording of any pre-screening questions. Submit the page copy, the ad copy and the pre-screener as one package rather than assuming the page is “just a website”. Confirm the specific expectation with your own board, because the boundary of what counts as material varies more than you would expect.

Why does a dedicated page outperform the study listing on our university site?

Because the two pages are written for different readers. The institutional listing exists to record the protocol accurately for reviewers, clinicians and registries; the recruitment page exists to help one person decide whether this applies to them and what happens if they get in touch. The dedicated page can also be edited by the study team once the wording is approved, carries campaign tracking, and is something a comms team will actually allow you to run ads to.

Can we put screening questions on the landing page itself?

Only if you are careful about what you store. Two or three yes/no questions used to branch the page — without saving the answers alongside contact details — are generally workable. As soon as identified health answers are stored, the tool holding them needs a BAA in the US or an appropriate processor arrangement under UK GDPR, and mainstream page builders including Unbounce do not offer that at self-serve pricing. The common solution is to keep the marketing copy in the page builder and hand off to REDCap or your EDC for real screening.

How much does Unbounce cost for a study team?

Starter is $29/mo ($22 annual), Build $99/mo ($74), Experiment $149/mo ($112, with unlimited A/B testing), and Optimize $249/mo ($187, adding Smart Traffic), with 25% off annual billing. Verified 18 August 2026. Most single studies are well served by Build for one approved version, moving to Experiment once you have two or three pre-approved variants worth splitting traffic between.

What about competitors like Leadpages or Instapage?

Both are credible landing page products with different emphases — Instapage skews towards agencies and enterprise ad teams, Leadpages towards simpler self-serve use — and either can host an approved recruitment page. We do not quote their prices here because we only publish prices we have read directly off a vendor pricing page and verified on a date. Check their current pages yourself, and ask all of them the same question: what happens to a form submission containing a health answer, and will you sign a BAA for it.

How should we handle A/B testing if every wording change needs approval?

Do not treat it as testing in the usual sense. Submit two or three complete variants in your initial approval package, each varying one meaningful element such as the headline framing or where the time commitment appears, so all of them arrive pre-approved. Then split traffic between things you are already permitted to say. The mistake is planning an iterative optimisation programme and discovering that a single amendment cycle consumes most of your recruitment window.

Does this apply to non-clinical research participant recruitment too?

Yes, with fewer constraints. A behavioural study, a cohort survey or a device usability panel has the same core problem — an unfindable page written for reviewers rather than participants — and benefits from the same fix. Your ethics committee may still review recruitment wording, and data protection obligations still apply to whatever the form collects, but the rules on implied benefit and consent-adjacent language are usually less restrictive than for an interventional trial.

Related on CASRAI

• Best landing page builders compared
• Unbounce review
• Conversion rate optimisation tools
• Electronic signature software with a BAA
• HIPAA-compliant fax services
• All software reviewed by CASRAI